Pharma

Your Article Summary

See Latest Articles

FDA Approves Alcons AcrySof IQ ReSTOR +3.0 D Intraocular Lens
Alcon, 01/13/09

Alcon, Inc., the world's leader in eye care and cataract surgery announced that the U.S. Food and Drug Administration (FDA) approved its +3.0 diopter add power AcrySof IQ ReSTOR IOL. This new lens, which was introduced in many major markets outside the United States earlier this year, is now approved in the U.S. for cataract surgery in patients with presbyopia. This lens is another technology advancement for the AcrySof IQ ReSTOR platform, which has been the number one choice of surgeons to correct presbyopia in cataract patients since it was introduced in 2005.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Abbott Seeks FDA Approval of New Dosage Strengths of SIMCOR
Abbott, 12/11/09

Recombinant Human Erythropoietin, Epogin Injection Application for Approval of Additional Indication of Chemotherapy-Induced Anemia
Chugai Pharmaceutical Co., 12/08/09

Synthon announces European approvals for Raloxifene
Synthon, 12/08/09

 See all of Drug/Product Approvals